ELOTUZUMAB for Bone lesion: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where ELOTUZUMAB was used for Bone lesion.
Most Reported Side Effects for ELOTUZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Plasma cell myeloma | 339 | 9.9% | 122 | 82 |
| Death | 234 | 6.8% | 234 | 10 |
| Malignant neoplasm progression | 227 | 6.6% | 88 | 77 |
| Pneumonia | 209 | 6.1% | 58 | 164 |
| Pyrexia | 183 | 5.3% | 35 | 136 |
| Drug ineffective | 137 | 4.0% | 15 | 26 |
| Neutropenia | 133 | 3.9% | 28 | 69 |
| Anaemia | 119 | 3.5% | 36 | 66 |
| Thrombocytopenia | 107 | 3.1% | 17 | 51 |
| Diarrhoea | 105 | 3.1% | 23 | 47 |
| Fatigue | 95 | 2.8% | 17 | 19 |
| Off label use | 93 | 2.7% | 14 | 26 |
| Sepsis | 86 | 2.5% | 50 | 68 |
| Platelet count decreased | 82 | 2.4% | 20 | 37 |
| Febrile neutropenia | 68 | 2.0% | 21 | 49 |
Other Indications for ELOTUZUMAB
Plasma cell myeloma (2,659)
Product used for unknown indication (703)
Plasma cell myeloma refractory (138)
Disease progression (9)
Plasma cell myeloma recurrent (9)
Immunosuppressant drug therapy (5)
Other Drugs Used for Bone lesion
DENOSUMAB (157)
ZOLEDRONIC ACID (79)
CYCLOPHOSPHAMIDE (18)
DEXAMETHASONE (16)
BORTEZOMIB (13)
LENALIDOMIDE (13)
PAMIDRONATE (10)
POMALIDOMIDE (10)
BELANTAMAB MAFODOTIN (9)
DARATUMUMAB (9)